Skip to main content
. 2011 Jul 5;22(1):248–258. doi: 10.1038/cr.2011.109

Table 1. Case description, sphere formation, and tumorigenic activity of CD44+ and CD54+ gastric cancer cells.

Case Sex/age Site Grade CD44+CD54+ expression (%) Sphere formation Tumor formation
Secondary tumor formation
CD44+CD54+ 1 Slice (cm3) 2 Total cell
1 F/71 Pyloric Moderate 0.4 No 103 (0/3) 0.05 (2/3) 3 × 106 (0/3) N/A
2 M/60 Cardial Moderate 1.8 Yes 103 (3/3) 0.06 (3/3) 3 × 106 (2/3) Yes
3 F/61 Corpus Moderate 0.6 No 103 (0/3) 0.07 (1/3) 3 × 106 (0/3) N/A
4 M/41 Pyloric Poor 1.3 Yes 103 (3/3) 0.05 (2/3) 3 × 106 (2/3) Yes
5 F/62 Cardial Moderate 7.0 Yes 103 (3/3) 0.05 (3/3) 3 × 106 (3/3) Yes
6 M/55 Pyloric Moderate 0.2 No 103 (0/3) 0.07 (2/3) 3 × 106 (0/3) N/A
7 M/53 Cardial Moderate with signet-ring cell 0.8 Yes 103 (3/3) 0.075 (2/3) 3 × 106 (2/3) Yes
8 M/62 Corpus Poor 19.7 Yes 103 (3/3) 0.06 (3/3) 3 × 106 (1/3) Yes
9 M/76 Fundus Moderate 6.1 Yes 103 (3/3) 0.07 (3/3) 2 × 106 (3/3) Yes
10 F/72 Pyloric Moderate 1.2 No 103 (0/3) 0.075 (3/3) 3 × 106 (0/3) N/A
11 F/59 Pyloric Moderate with signet-ring cell 2.2 Yes 103 (3/3) 0.068 (2/3) 2 × 106 (2/3) Yes
12 F/56 Pyloric Moderate with signet-ring cell 1.5 Yes 103 (3/3) 0.056 (3/3) 2 × 106 (1/3) Yes
13 M/58 Cardial Moderate 0.1 Yes 103 (3/3) 0.07 (3/3) 2 × 106 (1/3) Yes
14 M/55 Cardial Moderate 0.1 No 103 (0/3) 0.06 (2/3) 3 × 106 (0/3) N/A
15 M/77 Angular notch Moderate with signet-ring cell 2.3 Yes 103 (3/3) 0.05 (2/3) 2 × 106 (2/3) Yes
16 M/72 Angular notch Moderate 0.2 No 103 (0/3) 0.07 (3/3) 3 × 106 (0/3) N/A
17 M/41 Pyloric Moderate with signet-ring cell 0.7 Yes 103 (3/3) 0.075 (3/3) 2 × 106 (2/3) Yes
18 M/71 Angular notch Moderate with signet-ring cell 0.6 Yes 103 (3/3) 0.05 (2/3) 2 × 106 (2/3) Yes

1Number of CD44+CD54+ cells injected into mice (number of mice that have tumor formation in three mice).

2Volume of tissue directly cut from tumor (number of mice that have tumor formation in three mice). N/A: not available.

HHS Vulnerability Disclosure